<code id='6BA4D87EA8'></code><style id='6BA4D87EA8'></style>

<acronym id='6BA4D87EA8'></acronym>

<center id='6BA4D87EA8'><center id='6BA4D87EA8'><tfoot id='6BA4D87EA8'></tfoot></center><abbr id='6BA4D87EA8'><dir id='6BA4D87EA8'><tfoot id='6BA4D87EA8'></tfoot><noframes id='6BA4D87EA8'>

<optgroup id='6BA4D87EA8'><strike id='6BA4D87EA8'><sup id='6BA4D87EA8'></sup></strike><code id='6BA4D87EA8'></code></optgroup>

<b id='6BA4D87EA8'><label id='6BA4D87EA8'><select id='6BA4D87EA8'><dt id='6BA4D87EA8'><span id='6BA4D87EA8'></span></dt></select></label></b><u id='6BA4D87EA8'></u>

~~<i id='6BA4D87EA8'><strike id='6BA4D87EA8'><tt id='6BA4D87EA8'><pre id='6BA4D87EA8'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

explore

author：Wikipedia 2025-10-02 09:33:49 Page View：653

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The story of mRNA: From a loose idea to a tool that may help curb Covid
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

Wikipedia

The high cost of giving birth even with insurance

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

New lawsuit accuses health insurer Cigna of denying claims in bulk

New lawsuit accuses health insurer Cigna of denying claims in bulk

AnewlawsuitaccusesthehealthinsurerCignaofdenyingclaimsinbulk.JuliaRendleman/GettyImagesforEventiveMa

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Device maker Teleflex to acquire urology company for $600M

AdobeTeleflexannouncedplansonWednesdaytoacquirePaletteLifeSciences,themakerofaslateofgel-basedproduc

read more